American Elements Logo and U.S. Registered Trademark
Yttrium Phosphate
YPO4
Product
Product Code
Order or Specifications
99% Yttrium Phosphate
Y-PAT-02
Contact American Elements
99.9% Yttrium Phosphate
Y-PAT-03
Contact American Elements
99.99% Yttrium Phosphate
Y-PAT-04
Contact American Elements
99.999% Yttrium Phosphate
Y-PAT-05
Contact American Elements
Yttrium Phosphate is a moderately water and acid soluble Yttrium source for uses compatible with Phosphates. Yttrium Phosphate is generally immediately available in most volumes. High purity, submicron and nanopowder forms may be considered. Additional technical, research and safety (MSDS) information is available as is a Reference Calculator for converting relevant units of measurement.

Yttrium is a Block D, Group 3, Period 5 element. The electronic configuration is [Kr] 4d1 5s2. In its elemental form yttrium's CAS number is 7440-65-5. The yttrium atom has a radius of 177.6.pm and it's Van der Waals radius is 200.pm. Yttrium has the highest thermo-dynamic affinity for oxygen of any element. This characteristic is the basis for many of its applications. While not part of the rare earth series, it resembles the heavy rare earths which are sometimes referred to as the “yttrics” for this reason. Another unique characteristic derives from its ability to form crystals with useful properties. Yttrium is available as metal and compounds with purities from 99% to 99.999% (ACS grade to ultra high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder. Some of the many applications of yttrium include in ceramics for crucibles for molten reactive metals, in florescent lighting phosphors, computer displays and automotive fuel consumption sensors.Yttria stabilized zirconium oxide are used in high temperature applications, such as in thermal plasma sprays to protect aerospace high temperature surfaces and as an electrolyte in solid oxide fuel cells.

Formula CAS No. Appearance Molecular Weight Density Melting Point Boiling Point
YPO4 13990-54-0 183.88      
PRODUCT CATALOG Submicron & Nanopowder Tolling Ultra High Purity Sputtering Target Crystal Growth Rod, Plate, Powder, etc.
 
 
Periodic table of the elements science and academic information, elements and advanced materials data, scientific presentations and all pages, designs, concepts, logos, and color schemes herein are the copyrighted proprietary rights and intellectual property of American Elements. American Elements is a U.S. Registered Trademark. © 2001-2009. American Elements. All rights reserved.

 

Recent Research & Development for Yttrium

  • Liver transplantation after radioembolization in a patient with unresectable HCC. Luna LE, Kwo PY, Roberts LR, Mettler TA, Gansen DN, Andrews JC, Wiseman GA, Misra VL. Nat Rev Gastroenterol Hepatol. 2009 Nov;6(11):679-83. PMID: 19881519 [PubMed - in process]

  • Assessment of Neodymium:Yttrium-Aluminum-Garnet (Nd:YAG) laser fiber wear and tear grade during visual laser ablation of prostatic adenoma. Rózanski W, Klimek L, Jablonowski Z, Sosnowski M. Photomed Laser Surg. 2009 Oct;27(5):799-805. PMID: 19878030 [PubMed - in process]

  • Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option. Saxena A, Bester L, Chua TC, Chu FC, Morris DL. Ann Surg Oncol. 2009 Oct 30. [Epub ahead of print] PMID: 19876691 [PubMed - as supplied by publisher]

  • Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma. Fleming CJ, Andrews JC, Wiseman GA, Gansen DN, Roberts LR. J Vasc Interv Radiol. 2009 Nov;20(11):1460-3. PMID: 19875064 [PubMed - in process]

  • Genotoxic effects of 1064-nm Nd:YAG and 532-nm KTP lasers on fibroblast cell cultures. Senturk N, Bedir A, Bilgici B, Aydin F, Okuyucu A, Ozmen ZC, Turanli AY. Clin Exp Dermatol. 2009 Oct 23. [Epub ahead of print] PMID: 19874333 [PubMed - as supplied by publisher]

  • Axillary hair removal with 1064-nm Nd:YAG laser increases sweat production. Aydin F, Pancar GS, Senturk N, Bek Y, Yuksel EP, Canturk T, Turanli AY. Clin Exp Dermatol. 2009 Oct 23. [Epub ahead of print] PMID: 19874331 [PubMed - as supplied by publisher]

  • The management of treatment-resistant biliary calculi using percutaneous endourologic techniques. Ray AA, Davies ET, Duvdevani M, Razvi H, Denstedt JD. Can J Surg. 2009 Oct;52(5):407-12. PMID: 19865576 [PubMed - in process]

  • [Liver chemoembolization: an update.] Roche A. Bull Cancer. 2009 Oct 29. [Epub ahead of print] French. PMID: 19864205 [PubMed - as supplied by publisher]

  • Results of intraocular lens implantation with capsular tension ring in subluxated crystalline or cataractous lenses in children. Das P, Ram J, Brar GS, Dogra MR. Indian J Ophthalmol. 2009 Nov-Dec;57(6):431-6. PMID: 19861744 [PubMed - in process]

  • Quantitative PCR Analysis for Bcl-2/IgH in a Phase III Study of Yttrium-90 Ibritumomab Tiuxetan As Consolidation of First Remission in Patients With Follicular Lymphoma. Goff L, Summers K, Iqbal S, Kuhlmann J, Kunz M, Louton T, Hagenbeek A, Morschhauser F, Putz B, Lister A, Rohatiner A. J Clin Oncol. 2009 Oct 26. [Epub ahead of print] PMID: 19858392 [PubMed - as supplied by publisher]

  • Optimization of Radioembolic Effect with Extended-shelf-life Yttrium-90 Microspheres: Results from a Pilot Study. Lewandowski RJ, Riaz A, Ryu RK, Mulcahy MF, Sato KT, Kulik LM, Gates VL, Baker T, Omary R, Salem R. J Vasc Interv Radiol. 2009 Oct 23. [Epub ahead of print] PMID: 19854068 [PubMed - as supplied by publisher]

  • The Role of Tumor Vascularity in Predicting Survival after Yttrium-90 Radioembolization for Liver Metastases. Sato KT, Omary RA, Takehana C, Ibrahim S, Lewandowski RJ, Ryu RK, Salem R. J Vasc Interv Radiol. 2009 Oct 19. [Epub ahead of print] PMID: 19846320 [PubMed - as supplied by publisher]

  • Safety and Efficacy Assessment of Flow Redistribution by Occlusion of Intrahepatic Vessels Prior to Radioembolization in the Treatment of Liver Tumors. Bilbao JI, Garrastachu P, Herráiz MJ, Rodríguez M, Ińarrairaegui M, Rodríguez J, Hernández C, de la Cuesta AM, Arbizu J, Sangro B. Cardiovasc Intervent Radiol. 2009 Oct 20. [Epub ahead of print] PMID: 19841973 [PubMed - as supplied by publisher]

  • Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response. Gisselbrecht C, Vose J, Nademanee A, Gianni AM, Nagler A. Oncologist. 2009;14 Suppl 2:41-51. PMID: 19819923 [PubMed - in process]

  • Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidence. Morschhauser F, Dreyling M, Rohatiner A, Hagemeister F, Bischof Delaloye A. Oncologist. 2009;14 Suppl 2:17-29. PMID: 19819921 [PubMed - in process]

  • Harnessing the energy: development of radioimmunotherapy for patients with non-Hodgkin's lymphoma. Gregory SA, Hohloch K, Gisselbrecht C, Tobinai K, Dreyling M. Oncologist. 2009;14 Suppl 2:4-16. PMID: 19819920 [PubMed - in process]

  • Imaging in targeted delivery of therapy to cancer. Dancey G, Begent RH, Meyer T. Target Oncol. 2009 Oct 8. [Epub ahead of print] PMID: 19838639 [PubMed - as supplied by publisher]

  • Polymerization of Enantiopure Monomers Using Syndiospecific Catalysts: A New Approach To Sequence Control in Polymer Synthesis. Kramer JW, Treitler DS, Dunn EW, Castro PM, Roisnel T, Thomas CM, Coates GW. J Am Chem Soc. 2009 Oct 16. [Epub ahead of print] PMID: 19835375 [PubMed - as supplied by publisher]

  • [Minimally invasive tumor ablation in the liver] Wybranski C, Mohnike K, Ricke J. Anasthesiol Intensivmed Notfallmed Schmerzther. 2009 Oct;44(10):670-7; quiz 679. Epub 2009 Oct 15. German. PMID: 19834832 [PubMed - in process]

  • Intraarticular adalimumab in a patient with pigmented villonodular synovitis. Kobak S. Rheumatol Int. 2009 Oct 10. [Epub ahead of print] PMID: 19820943 [PubMed - as supplied by publisher]

 

 

 

 

American Elements Products can also be sourced at these sites:
 
 
 
electronics-ee.com